Printed in Great Britain Antibody to Hepatitis C Virus in Selected Groups of a Canadian Urban

In an anonymous survey, 433 sera from Canadian individuals of selected categories were tested for the presence of antibody to hepatitis C virus (HCV) using a recombinant antigen-based immunoassay. About 50 % of intravenous drug abusers (IVDA), 10 % of transfusion recipients and an overall average of 7.9 % of male homosexuals were reactive for antibody to HCV. Individuals with jaundice and negative hepatitis B virus (HBV) serology were not reactive for antibody to HCV compared with 26.7 % of those with positive HBV serology. Similarly 58 % of male Federal prisoners with positive HBV serology were also HCV-antibody reactive compared with 15 % of those with negative HBV serology. A prevalence of 1.2 % was recorded for individuals not in any of the above groups. Of 433 sera, 92 were reactive and the discrimination in absorbance values between reactive and not reactive samples was good except for 13 sera, eight of which gave values considerably higher than the average negative value and five which were just above the positive threshold. Non-A, non-B (NANB) hepatitis has been recognized as a clinically separate entity1 from hepatitis A and B, for which specific serological tests have been available for at least 15 years.2 Two types of NANB hepatitis have been identified based on epidemiological data